.svg){kind=icon}
Introduction
The implementation of a field‑based medical service (usually a medical science liaison [MSL] team) is widely regarded as a must‑have in the early stages of product launch readiness – whether to support the delivery of Phase 3 clinical trials, initiate early external engagement with potential future prescribers and key opinion leaders (KOLs), or begin Medical Affairs initiatives.
Content placeholder - see full article
